CEBPB and breast cancer: Here, we showed that PGAM1 can upregulate cAMP levels and then activate the AMPK signaling pathway, altering the phosphorylation level of CEBPB, thereby affecting its transcriptional activity and combination with ASS1, which suppress the ASS1 expression and contribute to BC progression.